Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Safety Changes: Cymbalta, Crestor, Rapamune
Link ID 3963
Title FDA Safety Changes: Cymbalta, Crestor, Rapamune
Url http://www.medscape.com/viewarticle/571261?src=rss
Description The FDA has approved revisions to the safety labeling for duloxetine HCl delayed-release capsules, rosuvastatin calcium tablets, and sirolimus tablets and oral solution. Medscape Medical News
Category Articles > Business of Medicine
Keywords
Date Mar 13, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. WHO Studies Tamiflu Resistance After New Report
  The World Health Organisation (WHO) said on Tuesday it was studying whether some seasonal flu viruses may be resistant to Tamiflu, after a study showed high levels of resistance to the widely-used drug in parts of Europe. Reuters Health Information
Category:   Articles > Business of Medicine


2. Quality of Care in Our Hospitals: Paradoxes, Branding, and Leadership
  NMA 2007: Regardless of where your hospital stood yesterday, tomorrow it will be judged by new standards of quality measures.
Medscape Internal Medicine
Category:   Articles > Business of Medicine


3. Health Net Profit Rises, but Forecast Is Weak
  Insurer Health Net Inc posted a 46 percent rise in quarterly profit Tuesday, helped by its Medicare plans for older Americans, but forecast 2008 earnings below Wall Street expectations. Reuters Health Information
Category:   Articles > Business of Medicine


4. Technophile Offers Tips on Increasing Productivity
  An Australian physician shares the tools and tips that she has gleaned from the Internet to help students and physicians get more organized.
Medscape Med Students
Category:   Articles > Business of Medicine


5. Herbalife Rebuts Lead Claims, Says No Safety Issues
  Herbalife Ltd said on Sunday that independent lab tests have confirmed its products do not contain lead levels that would require labeling under a California law, disputing a prior complaint by a critic of the dietary supplement company. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS